Impel Pharmaceuticals to Participate in Guggenheim 4th

SEATTLE, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative...

Related Keywords

New York ,United States ,Adrian Adams ,Christina Tartaglia ,Melyssa Weible ,Impel Pharmaceuticals ,Impel Pharmaceuticals Inc ,Elixir Health Public Relations ,Nasdaq ,Chief Executive Officer ,Annual Immunology ,Neurology Day ,Nasdaq Impl ,Mpl ,